Austrianova reports successful metronomic treatment using Cell-in-a-Box® in an animal model of pancreatic cancer
Austrianova reports that one dose of Cell-in-a-Box® encapsulated cells and multiple rounds (metronomic) of low dose ifosfamide control pancreatic cancer. SINGAPORE, December 19, 2023 /EINPresswire.com/ -- Austrianova, a member of the SGAustria group of …